funding - MarketOpen Australia

October 30, 2024 Off

Tryp Therapeutics (ASX:TYP) sets the stage with $6M strategic injection for psilocin clinical trials

Tryp Therapeutics (ASX:TYP) has secured AUD $6 million in funding to accelerate its flagship IV-infused psilocin treatment, TRP-8803, marking a pivotal step in advancing clinical solutions for treatment-resistant psychiatric conditions.

November 6, 2023 Off

Elixir (ASX:EXR) to share Grandis daydreams with Origin (ASX:ORG)

By Amanda Ellis

Elixir Energy complete a lucrative gas information sharing deal with Brookside and Origin Energy.

Tag: funding

Tryp Therapeutics (ASX:TYP) sets the stage with $6M strategic injection for psilocin clinical trials

Elixir (ASX:EXR) to share Grandis daydreams with Origin (ASX:ORG)

Contact info

Important links

Follow us

Tryp Therapeutics (ASX:TYP) sets the stage with $6M strategic injection for psilocin clinical trials

Elixir (ASX:EXR) to share Grandis daydreams with Origin (ASX:ORG)

Subscribe